What is driving BAYN.DE stock today?

BAYN.DE stock moved lower ahead of Bayer’s earnings on 04 Mar 2026. Traders priced litigation charges, guidance risk, and segment revenue for Pharmaceuticals and Crop Science.

How does Bayer’s valuation affect BAYN.DE stock outlook?

Valuation shows PE **-191.55** and P/S **0.82**. High leverage and negative EPS compress upside until earnings confirm improved margins or lower legal costs for BAYN.DE stock.

What targets should investors watch for BAYN.DE stock?

Watch the practical range: conservative **€32.00**, base **€45.00**, and bullish **€60.00**. Also monitor Meyka AI quarterly target **€59.74** and yearly **€16.08** for scenario context.

How reliable is the Meyka AI forecast for BAYN.DE stock?

Meyka AI's forecasts are model‑based projections. They offer scenario guidance but are not guarantees. Use them alongside company disclosures and analyst reports for BAYN.DE stock decisions.

DE Stocks

Down 8.34% intraday 04 Mar 2026: Bayer (BAYN.DE XETRA) earnings today could reset targets

ByHuzaifa Zahoor March 4, 2026March 4, 2026

Bayer AG shares fell 8.34% intraday to €37.23 on 04 Mar 2026 as traders positioned ahead of the company’s earnings announcement. The move came on XETRA during active volume of 1,456,022 shares versus a three‑month average of 3,612,262. BAYN.DE stock faces focus on litigation charges, crop science trends, and drug sales for KERENDIA ahead of the results. Investors will watch guidance, cash flow, and any litigation updates that could drive a larger post‑report swing.